DM

Deerfield Management Portfolio holdings

AUM $5.51B
1-Year Est. Return 12.76%
This Quarter Est. Return
1 Year Est. Return
+12.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.01B
AUM Growth
+$259M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$88.1M
2
+$62.8M
3
+$39.4M
4
LRMR icon
Larimar Therapeutics
LRMR
+$35.6M
5
PHAT icon
Phathom Pharmaceuticals
PHAT
+$26.8M

Top Sells

1
+$85.2M
2
+$69.6M
3
+$55M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$53.1M
5
DAWN icon
Day One Biopharmaceuticals
DAWN
+$49.7M

Sector Composition

1 Healthcare 53.67%
2 Financials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$376M 7.48%
19,341,024
2
$161M 3.2%
1,512,714
-500,000
3
$154M 3.07%
8,223,536
-2,927,261
4
$114M 2.27%
2,535,369
-141,522
5
$112M 2.24%
528,703
6
$94.9M 1.89%
1,537,539
-15,100
7
$90.9M 1.81%
10,673,700
-10,000,000
8
$88.1M 1.75%
+330,000
9
$76.1M 1.52%
4,244,098
-969,902
10
$73.5M 1.46%
4,855,005
+159,985
11
$65.7M 1.31%
13,740,205
-1,280,285
12
$62.8M 1.25%
+4,896,000
13
$62M 1.23%
3,720,901
+255,000
14
$57M 1.14%
2,891,587
+2,000,000
15
$54.2M 1.08%
16,941,357
+11,111,108
16
$50.5M 1.01%
2,521,553
+535,629
17
$46.1M 0.92%
2,491,490
-3,759,474
18
$45.3M 0.9%
2,653,231
+35,283
19
$44.3M 0.88%
2,966,345
-2,910,460
20
$43.4M 0.86%
5,390,103
+1,757,352
21
$42.7M 0.85%
2,032,335
-1,212,099
22
$39.4M 0.78%
813,112
-347,203
23
$38.7M 0.77%
3,933,137
24
$37.4M 0.74%
1,466,600
+694,600
25
$37.1M 0.74%
8,692,561
+100,100
1
2 3 4 5